RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+7.97%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$646M
AUM Growth
+$646M
(+16%)
Cap. Flow
+$79.4M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
39.44%
Holding
93
New
15
Increased
55
Reduced
6
Closed
10
Top Buys
| 1 |
HCA Healthcare
HCA
|
$16.4M |
| 2 |
AbbVie
ABBV
|
$14.4M |
| 3 |
Medtronic
MDT
|
$6.97M |
| 4 |
Danaher
DHR
|
$6.46M |
| 5 |
AGN
Allergan plc
AGN
|
$5.31M |
Top Sells
| 1 |
ITMN
INTERMUNE INC
ITMN
|
$23.8M |
| 2 |
STJ
St Jude Medical
STJ
|
$6.93M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$5.93M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
$5.35M |
| 5 |
Charles River Laboratories
CRL
|
$3.81M |
Sector Composition
| 1 | Healthcare | 79.22% |
| 2 | Industrials | 2.23% |
| 3 | Financials | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $38.6M | 5.98% | 363,000 +23,000 | +7% | +$2.45M |
|
|
2
Medtronic
MDT
$119B
| $32.7M | 5.06% | 527,500 +112,500 | +27% | +$6.97M |
|
|
3
AbbVie
ABBV
$372B
| $30.3M | 4.69% | 525,000 +250,000 | +91% | +$14.4M |
|
4
Merck
MRK
$210B
| $28.2M | 4.36% | 475,000 | – | – |
|
5
McKesson
MCK
$85.4B
| $25M | 3.87% | 128,500 +9,500 | +8% | +$1.85M |
|
|
6
HCA Healthcare
HCA
$94.5B
| $22.6M | 3.49% | 320,250 +232,750 | +266% | +$16.4M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $21.2M | 3.28% | 87,750 +22,000 | +33% | +$5.31M |
|
8
Amgen
AMGN
$155B
| $20.4M | 3.15% | 145,000 +30,000 | +26% | +$4.21M |
|
9
Biogen
BIIB
$19.4B
| $20.3M | 3.14% | 61,350 +1,350 | +2% | +$447K |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $15.7M | 2.43% | 166,000 +6,000 | +4% | +$569K |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $14.9M | 2.3% | 89,750 +4,000 | +5% | +$663K |
|
|
THOR
12
DELISTED
THORATEC CORPORATION
THOR
| $13.9M | 2.15% | 521,000 +28,800 | +6% | +$770K |
|
13
Thermo Fisher Scientific
TMO
$186B
| $13.2M | 2.04% | 108,500 +500 | +0.5% | +$60.8K |
|
|
AVNR
14
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $13.1M | 2.03% | 1,100,000 +400,000 | +57% | +$4.77M |
|
15
Cooper Companies
COO
$13.4B
| $10.7M | 1.66% | 68,750 +5,750 | +9% | +$896K |
|
|
AVDL
16
Avadel Pharmaceuticals
AVDL
$1.43B
| $10.5M | 1.63% | 735,000 -40,000 | -5% | -$572K |
|
17
Humana
HUM
$36.5B
| $10.4M | 1.6% | 79,500 +7,000 | +10% | +$912K |
|
18
CVS Health
CVS
$92.8B
| $10.3M | 1.6% | 130,000 +8,750 | +7% | +$696K |
|
|
PCYC
19
DELISTED
PHARMACYCLICS INC
PCYC
| $10M | 1.55% | 85,250 +31,000 | +57% | +$3.64M |
|
|
EVHC
20
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $9.9M | 1.53% | 285,500 +120,500 | +73% | +$4.18M |
|
21
Pacira BioSciences
PCRX
$1.2B
| $9.89M | 1.53% | 102,000 +24,250 | +31% | +$2.35M |
|
22
Acadia Healthcare
ACHC
$2.12B
| $9.85M | 1.52% | 203,000 +83,000 | +69% | +$4.03M |
|
|
ATHN
23
DELISTED
Athenahealth, Inc.
ATHN
| $8.92M | 1.38% | 67,750 +5,500 | +9% | +$724K |
|
|
SRGA
24
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $8.89M | 1.38% | 1,859,600 +109,600 | +6% | +$524K |
|
|
HRC
25
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.83M | 1.37% | 213,000 +18,000 | +9% | +$746K |
|